Investors
DiagnoCure’s mission is to be the leading developer and provider of high-value diagnostics for the detection and management of cancer.
STOCK INFORMATION
| Symbol | TSX: CUR |
|---|---|
| Last trade | 1.27 |
| Open | 1.32 |
| Net change | -0.05 |
| High | 1.39 |
| Low | 1.23 |
| Volume | 124,300 |
| As of | 2010-03-18 15:58 EST |
| $CAN. Quotes are delayed. For information purposes only. |
|
Annual General Meeting of Shareholders
March 17, 2010, 2:00 pm
St-James Club
Montreal, Quebec